Anavex Life Sciences Corp. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2010 Sep2011 Sep2012 Sep2013 Sep2014 Sep2015 Sep2016 Sep2017 Sep2018 Sep2019 Sep2020 Sep2021 Sep2022 Sep2023 Sep2024 Sep2025
Operating Activities
Net Income -12.11M-14.74M-13.46M-17.25M-26.29M-26.28M-37.91M-47.98M-47.51M-43.00M
Share-based Compensation 0.77M1.27M0.30M1.00M0.64M1.63M5.06M4.14M5.52M6.43M4.88M8.23M18.40M16.40M9.44M11.55M
Deferred Taxes -1.40M
Gains from Investment Securities 0.20M0.02M0.00M24.45M4.20M4.63M0.60M9.32M
Cash from Operations -4.59M-3.80M-1.69M-0.78M-2.66M-4.23M-9.24M-9.02M-12.58M-18.53M-21.29M-30.38M-24.24M-27.79M-30.81M-39.04M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.84M0.07M0.10M1.92M4.52M0.01M
Amortization of Deferred Charges 0.06M0.04M0.06M0.00M1.12M
Depreciation & Amortization (CF) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Change in Working Capital
Change in Receivables 0.04M-0.04M-0.00M0.08M0.00M-0.05M0.23M0.77M
Change in Account Payables 0.04M0.68M0.47M0.75M-0.91M0.50M5.30M-5.38M
Change in Accured Expenses 0.51M1.13M2.28M0.47M-0.30M1.31M0.78M0.55M0.26M0.59M1.80M2.30M0.33M1.35M-2.46M-0.94M
Change in Taxes 0.77M2.21M4.29M-5.94M-0.48M-0.26M-1.64M
Other Working Capital Changes 0.02M-0.01M-0.01M0.03M0.07M0.08M0.16M0.92M-0.80M-0.06M-0.09M-0.00M0.30M0.28M-0.50M
Investing Activities
Capital Expenditures 0.00M0.00M
Cash from Investing Activities -0.00M-0.00M
Financing Activities
Other financing activities 0.01M0.79M0.10M0.05M0.40M5.55M0.71M
Cash from Financing Activities 4.51M3.67M1.57M1.11M9.58M12.26M3.13M27.27M8.07M17.78M28.35M153.24M21.29M29.65M11.97M9.43M
Additional items
Change in Cash -0.09M-0.13M-0.12M0.33M6.92M8.03M-6.10M18.25M-4.51M-0.75M7.06M122.86M-2.95M1.87M-18.84M-29.61M
Free Cash Flow -4.60M-3.80M-1.69M-0.78M-2.66M-4.23M-9.24M-9.02M-12.58M-18.53M-21.29M-30.38M-24.24M-27.79M-30.81M-39.04M
Net Cash Flow -0.09M-0.13M-0.12M0.33M6.92M8.03M-6.10M18.25M-4.51M-0.75M7.06M122.86M-2.95M1.87M-18.84M-29.61M